PGAM
Princeton Global Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.69M | Sell |
15,025
-186
| -1% | -$82.8K | 1.21% | 23 |
|
2025
Q1 | $7.37M | Buy |
15,211
+79
| +0.5% | +$38.3K | 1.46% | 19 |
|
2024
Q4 | $6.09M | Sell |
15,132
-74
| -0.5% | -$29.8K | 1.14% | 25 |
|
2024
Q3 | $7.07M | Buy |
15,206
+122
| +0.8% | +$56.7K | 1.38% | 18 |
|
2024
Q2 | $7.07M | Buy |
15,084
+880
| +6% | +$412K | 1.56% | 16 |
|
2024
Q1 | $5.94M | Sell |
14,204
-846
| -6% | -$354K | 1.41% | 18 |
|
2023
Q4 | $6.12M | Buy |
15,050
+255
| +2% | +$104K | 1.54% | 16 |
|
2023
Q3 | $5.14M | Buy |
14,795
+688
| +5% | +$239K | 1.46% | 16 |
|
2023
Q2 | $4.96M | Sell |
14,107
-1,261
| -8% | -$444K | 1.45% | 15 |
|
2023
Q1 | $4.84M | Buy |
15,368
+400
| +3% | +$126K | 1.39% | 17 |
|
2022
Q4 | $4.32M | Sell |
14,968
-55
| -0.4% | -$15.9K | 1.4% | 16 |
|
2022
Q3 | $4.35M | Buy |
15,023
+40
| +0.3% | +$11.6K | 1.52% | 15 |
|
2022
Q2 | $4.22M | Sell |
14,983
-219
| -1% | -$61.7K | 1.36% | 17 |
|
2022
Q1 | $3.97M | Sell |
15,202
-580
| -4% | -$151K | 1.1% | 23 |
|
2021
Q4 | $3.47M | Sell |
15,782
-1,058
| -6% | -$232K | 0.97% | 28 |
|
2021
Q3 | $3.06M | Buy |
16,840
+283
| +2% | +$51.3K | 0.93% | 30 |
|
2021
Q2 | $3.34M | Sell |
16,557
-652
| -4% | -$131K | 1.02% | 27 |
|
2021
Q1 | $3.7M | Buy |
17,209
+4
| +0% | +$860 | 1.2% | 19 |
|
2020
Q4 | $4.07M | Sell |
17,205
-28
| -0.2% | -$6.62K | 1.42% | 17 |
|
2020
Q3 | $4.69M | Buy |
17,233
+258
| +2% | +$70.2K | 1.89% | 9 |
|
2020
Q2 | $4.93M | Buy |
16,975
+255
| +2% | +$74K | 1.54% | 12 |
|
2020
Q1 | $3.98M | Buy |
16,720
+2,175
| +15% | +$518K | 1.76% | 11 |
|
2019
Q4 | $3.18K | Buy |
14,545
+1,150
| +9% | +$252 | 1.29% | 18 |
|
2019
Q3 | $2.25M | Buy |
13,395
+446
| +3% | +$74.8K | 1.28% | 21 |
|
2019
Q2 | $2.38M | Buy |
12,949
+318
| +3% | +$58.3K | 1.43% | 17 |
|
2019
Q1 | $2.32M | Sell |
12,631
-7,180
| -36% | -$1.32M | 1.59% | 14 |
|
2018
Q4 | $3.28M | Buy |
+19,811
| New | +$3.28M | 2.9% | 4 |
|